187 related articles for article (PubMed ID: 29851132)
1. Pityriasis rubra pilaris-like erythroderma secondary to phosphoinositide 3-kinase inhibition.
Dewan AK; Sowerby L; Jadeja S; Lian C; Wen P; Brown JR; Fisher DC; LeBoeuf NR
Clin Exp Dermatol; 2018 Dec; 43(8):890-894. PubMed ID: 29851132
[TBL] [Abstract][Full Text] [Related]
2. Pityriasis rubra pilaris-like reaction induced by imatinib.
Plana A; Carrascosa JM; Vilavella M; Ferrandiz C
Clin Exp Dermatol; 2013 Jul; 38(5):520-2. PubMed ID: 23777493
[TBL] [Abstract][Full Text] [Related]
3. [A new case of pityriasis rubra pilaris-like eruption associated with ponatinib, a tyrosine kinase inhibitor].
Krygier J; Leemans G; Forsyth R; de Becker A; Gutermuth J; Grosber M
Ann Dermatol Venereol; 2018 Nov; 145(11):665-670. PubMed ID: 29903676
[TBL] [Abstract][Full Text] [Related]
4. Pityriasis Rubra Pilaris-Like Reaction Induced by a Tyrosine Kinase Inhibitor, the Ponatinib.
Mongereau M; Hillion B; Fouillard L; Boivin JF; Gaudron S
Am J Dermatopathol; 2021 May; 43(5):394-395. PubMed ID: 33264130
[No Abstract] [Full Text] [Related]
5. Case of pityriasis rubra pilaris progressed to generalized erythroderma following blockade of interleukin-17A, but improved after blockade of interleukin-12/23 p40.
Matsuda T; Yamazaki F; Ueda-Hayakawa I; Kambe N; Okamoto H
J Dermatol; 2019 Jan; 46(1):70-72. PubMed ID: 30506728
[TBL] [Abstract][Full Text] [Related]
6. Pityriasis Rubra Pilaris With Extensive Follicular Acantholysis Resembling Pemphigus Vulgaris: A Case Report.
Lilo MT; Yan S; Chapman MS; Linos K
Am J Dermatopathol; 2019 Jan; 41(1):37-39. PubMed ID: 30045068
[TBL] [Abstract][Full Text] [Related]
7. Acantholytic pityriasis rubra pilaris associated with topical use of imiquimod 5%: case report and literature review.
Leite OG; Tagliolatto S; Souza EM; Cintra ML
An Bras Dermatol; 2020; 95(1):63-66. PubMed ID: 31789270
[TBL] [Abstract][Full Text] [Related]
8. Pityriasis rubra pilaris-like eruption associated with the multikinase inhibitor ponatinib.
Jack A; Mauro MJ; Ehst BD
J Am Acad Dermatol; 2013 Nov; 69(5):e249-e250. PubMed ID: 24124847
[No Abstract] [Full Text] [Related]
9. Pityriasis rubra pilaris: the clinical context of acantholysis and other histologic features.
Ko CJ; Milstone LM; Choi J; McNiff JM
Int J Dermatol; 2011 Dec; 50(12):1480-5. PubMed ID: 22097993
[TBL] [Abstract][Full Text] [Related]
10. [Erythroderma after corticosteroid withdrawal in papulosquamous dermatosis in children. Diagnosis: pityriasis rubra pilaris, classic juvenile type].
Terheyden P; Hofmann UB; Hamm H; Bröcker EB
Hautarzt; 2001 Nov; 52(11):1058-61. PubMed ID: 11757463
[No Abstract] [Full Text] [Related]
11. Hyperkeratotic Skin Adverse Events Induced by Anticancer Treatments: A Comprehensive Review.
Vastarella M; Fabbrocini G; Sibaud V
Drug Saf; 2020 May; 43(5):395-408. PubMed ID: 31981081
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of erythrodermic pityriasis rubra pilaris with acitretin.
Atzori L; Zanniello R; Lappi A; Pinna AL; Ferreli C; Rongioletti F; Pilloni L
Dermatol Ther; 2018 Sep; 31(5):e12694. PubMed ID: 30230135
[No Abstract] [Full Text] [Related]
13. Pityriasis rubra pilaris: evolution of challenges in promising treatment options.
Sehgal VN; Srivastava G; Verma P
Skinmed; 2012; 10(1):18-23. PubMed ID: 22324172
[TBL] [Abstract][Full Text] [Related]
14. Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine.
Hunjan MK; Roberts C; Karim S; Hague J
Clin Exp Dermatol; 2022 Jan; 47(1):188-190. PubMed ID: 34379821
[TBL] [Abstract][Full Text] [Related]
15. Bullous erythroderma: novel association of pityriasis rubra pilaris with bullous pemphigoid.
Genovese G; Muratori S; Berti E; Marzano AV
Clin Exp Dermatol; 2019 Jan; 44(1):73-75. PubMed ID: 30129048
[No Abstract] [Full Text] [Related]
16. Drugs associated with development of pityriasis rubra pilaris: A systematic review.
Mufti A; Lytvyn Y; Maliyar K; Sachdeva M; Yeung J
J Am Acad Dermatol; 2021 Apr; 84(4):1071-1081. PubMed ID: 32687965
[No Abstract] [Full Text] [Related]
17. Successful treatment of pityriasis rubra pilaris with adalimumab - case report.
Bravo EA; Carrion L; Paucar SM; Mendoza R; Rivera C
Dermatol Online J; 2014 Apr; 20(4):22374. PubMed ID: 24746310
[TBL] [Abstract][Full Text] [Related]
18. [Pityriasis rubra pilaris].
Artik S; Kuhn A; Neumann NJ; Ruzicka T; Megahed M
Hautarzt; 2004 Oct; 55(10):980-3. PubMed ID: 15365642
[TBL] [Abstract][Full Text] [Related]
19. Dermatomyositis with a pityriasis rubra pilaris-like eruption: an uncommon cutaneous manifestation in dermatomyositis.
Polat M; Lenk N; Ustün H; Oztaş P; Artüz F; Alli N
Pediatr Dermatol; 2007; 24(2):151-4. PubMed ID: 17461814
[TBL] [Abstract][Full Text] [Related]
20. Erythroderma secondary to pityriasis rubra pilaris.
Gomez-Moyano E; Crespo-Erchiga A
Indian J Med Res; 2019 Aug; 150(2):206-207. PubMed ID: 31670278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
